Identifying Factors Underlying the Discontinuation of Triptans

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Todd J. Schwedt, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT00890357
First received: April 27, 2009
Last updated: March 27, 2013
Last verified: March 2013

April 27, 2009
March 27, 2013
August 2009
June 2012   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00890357 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Identifying Factors Underlying the Discontinuation of Triptans
Identifying Factors Underlying the Discontinuation of Triptans

The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Adult Specialty Headache Clinics

  • Migraine
  • Medication Adherence
Not Provided
  • Triptan User
  • Triptan Discontinued
Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ. Identifying the factors underlying discontinuation of triptans. Headache. 2014 Feb;54(2):278-89. doi: 10.1111/head.12198. Epub 2013 Sep 3.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
292
June 2012
June 2012   (final data collection date for primary outcome measure)

Triptan User Inclusion Criteria:

  • Episodic Migraine or Chronic Migraine
  • Have used a triptan medication in the prior 3 months
  • Have used triptan medications for at least 1 year

Triptan Discontinuation Inclusion Criteria:

  • Episodic Migraine or Chronic Migraine
  • Used any triptan medication in the last 2 years
  • Have not used a triptan medication in the last 6 months
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00890357
09-0111
Yes
Todd J. Schwedt, Mayo Clinic
Mayo Clinic
Merck Sharp & Dohme Corp.
Principal Investigator: Todd Schwedt, MD Mayo Clinic
Mayo Clinic
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP